# Off Label Use of Infliximab in Adult Patients With Severe Eosinophilic Esophagitis

> **NCT00523354** · PHASE2 · COMPLETED · sponsor: **Swiss EE Study Group**

## Conditions studied

- Esophagitis

## Interventions

- **DRUG:** Infliximab

## Key facts

- **NCT ID:** NCT00523354
- **Lead sponsor:** Swiss EE Study Group
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2007-09
- **Final completion:** 2007-10
- **Target enrollment:** — (—)
- **Last updated:** 2009-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00523354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00523354, "Off Label Use of Infliximab in Adult Patients With Severe Eosinophilic Esophagitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00523354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*